Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Merck
MRK
|
$2.43B |
| 2 |
Abbott
ABT
|
$1.44B |
| 3 |
Honeywell
HON
|
$1.01B |
| 4 |
Emerson Electric
EMR
|
$756M |
| 5 |
American International
AIG
|
$749M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.76B |
| 2 |
TJX Companies
TJX
|
$1.65B |
| 3 |
Baxter International
BAX
|
$1.17B |
| 4 |
Amazon
AMZN
|
$937M |
| 5 |
Starbucks
SBUX
|
$850M |
Sector Composition
| 1 | Healthcare | 24.3% |
| 2 | Technology | 15.49% |
| 3 | Financials | 14.45% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Flowserve
FLS
$7.02B
| $335M | 0.07% |
10,907,736
+258,083
| +2% | +$7.92M |
|
277
Sarepta Therapeutics
SRPT
$1.78B
| $331M | 0.07% |
2,554,064
-4,805
| -0.2% | -$623K |
|
278
iShares Core MSCI EAFE ETF
IEFA
$150B
| $331M | 0.07% |
5,365,253
+1,409,823
| +36% | +$86.9M |
|
279
Axon Enterprise
AXON
$58.7B
| $330M | 0.07% |
1,989,025
-66,912
| -3% | -$11.1M |
|
280
LPL Financial
LPLA
$29.2B
| $330M | 0.07% |
1,524,273
-898,422
| -37% | -$194M |
|
281
CarMax
KMX
$9.21B
| $322M | 0.06% |
5,287,125
+1,599,560
| +43% | +$97.4M |
|
282
Cabot Corp
CBT
$4.34B
| $321M | 0.06% |
4,798,288
-109,895
| -2% | -$7.35M |
|
283
BP
BP
$90.8B
| $320M | 0.06% |
9,166,566
+1,643,847
| +22% | +$57.4M |
|
284
IQVIA
IQV
$32.4B
| $320M | 0.06% |
1,559,767
| – | – |
|
285
Synaptics
SYNA
$2.7B
| $319M | 0.06% |
3,351,926
-226,958
| -6% | -$21.6M |
|
286
Haemonetics
HAE
$2.63B
| $317M | 0.06% |
4,034,753
-1,331,646
| -25% | -$105M |
|
287
Okta
OKTA
$16.4B
| $314M | 0.06% |
4,602,603
+501,235
| +12% | +$34.2M |
|
|
NARI
288
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $314M | 0.06% |
4,938,574
-260,652
| -5% | -$16.6M |
|
289
Integra LifeSciences
IART
$1.18B
| $313M | 0.06% |
5,574,026
+364,403
| +7% | +$20.4M |
|
290
Copart
CPRT
$47.2B
| $310M | 0.06% |
5,091,334
+2,835,265
| +126% | +$173M |
|
291
H&R Block
HRB
$6.74B
| $308M | 0.06% |
8,436,857
+27,774
| +0.3% | +$1.01M |
|
292
NetApp
NTAP
$22.6B
| $307M | 0.06% |
5,118,849
-878,520
| -15% | -$52.8M |
|
293
CVS Health
CVS
$92.8B
| $306M | 0.06% |
3,287,001
-4,169,812
| -56% | -$389M |
|
294
Jazz Pharmaceuticals
JAZZ
$7.75B
| $306M | 0.06% |
1,917,890
-37,592
| -2% | -$5.99M |
|
295
Credit Acceptance
CACC
$5.78B
| $304M | 0.06% |
641,379
-20,009
| -3% | -$9.49M |
|
296
Element Solutions
ESI
$6.21B
| $303M | 0.06% |
16,643,324
+52,785
| +0.3% | +$960K |
|
297
AvalonBay Communities
AVB
$27.9B
| $301M | 0.06% |
1,861,337
-340,435
| -15% | -$55M |
|
298
Intuitive Surgical
ISRG
$170B
| $300M | 0.06% |
1,131,689
-137,049
| -11% | -$36.4M |
|
299
Cytokinetics
CYTK
$4.23B
| $300M | 0.06% |
6,542,724
+1,706,244
| +35% | +$78.2M |
|
300
EXL Service
EXLS
$7.07B
| $298M | 0.06% |
1,759,889
+141,826
| +9% | +$24M |
|